Inhibition of hepatic uptake transporters by flavonoids

European Journal of Pharmaceutical Sciences

Volumn 46, Issue 1-2, 2012, Pages 79-85

  Mandery, Kathrin ^a   Balk, Bettina ^a   Bujok, Krystyna ^a   Schmidt, Ingrid ^a   Fromm, Martin F ^a   Glaeser, Hartmut ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Atorvastatin; Flavonoids; Food drug interaction; Herbal drugs; Inhibition; SLC transporter

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; APIGENIN; ATORVASTATIN; AURANTIIN; BROMSULFOPHTHALEIN; FLAVONOID; KAEMPFEROL; NARINGENIN; ORGANIC ANION TRANSPORT PROTEIN 1B1; ORGANIC ANION TRANSPORT PROTEIN 1B3; ORGANIC ANION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 1; QUERCETIN; RUTOSIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEK293; DRUG ACTIVITY; DRUG INHIBITION; FOOD DRUG INTERACTION; GINKGO BILOBA; GRAPEFRUIT; HUMAN; HUMAN CELL; IC 50; MAXIMUM PLASMA CONCENTRATION; PORTAL VEIN BLOOD; PRIORITY JOURNAL;

1-METHYL-4-PHENYLPYRIDINIUM; APIGENIN; BIOLOGICAL TRANSPORT; FLAVANONES; FLAVONOIDS; FOOD-DRUG INTERACTIONS; HEK293 CELLS; HEPATOCYTES; HEPTANOIC ACIDS; HUMANS; INHIBITORY CONCENTRATION 50; KAEMPFEROLS; METFORMIN; ORGANIC ANION TRANSPORTERS; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; ORGANIC CATION TRANSPORTER 1; PYRROLES; QUERCETIN; RUTIN; SULFOBROMOPHTHALEIN; TRITIUM;

EID: 84859218859     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.02.014     Document Type: Article

References (38)

1. Alvarez, A.I., Real, R., Pérez, M., Mendoza, G., Prieto, J.G., Merino, G., 2010. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response. J. Pharm. Sci. 99, 598-617.
2. Bailey, D.G., Dresser, G.K., Leake, B.F., Kim, R.B., 2007. Naringin is amajor and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin. Pharmacol. Ther. 81, 495-502. (Pubitemid 46452308)
3. Baltes, M.R., Dubois, J.G., Hanocq, M., 2001. Application to drug-food interactions of living cells as in vitro model expressing cytochrome P450 activity: enzyme inhibition by lemon juice. Talanta 54, 983-987. (Pubitemid 32613150)
4. Boots, A.W., Haenen, G.R., Bast, A., 2008. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 585, 325-337.
5. Boulton, D.W., Walle, U.K., Walle, T., 1998. Extensive binding of the bioflavonoid quercetin to human plasma proteins. J. Pharm. Pharmacol. 50, 243-249. (Pubitemid 28102584)
6. Cao, H., Chen, L., Xiao, J., 2011. Binding citrus flavanones to human serum albumin: effect of structure on affinity. Mol. Biol. Rep. 38, 2257-2262.
7. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
8. Dangles, O., Dufour, C., Bret, S., 1999. Flavonol-serum albumin complexation. Two-electron oxidation of flavonols and their complexes with serum albumin. J. Chem. Soc., Perkin Trans. 2, 737-744. (Pubitemid 129639869)
9. de Vries, J.H., Hollman, P.C., Meyboom, S., Buysman, M.N., Zock, P.L., van Staveren, W.A., Katan, M.B., 1998. Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake. Am. J. Clin. Nutr. 68, 60-65. (Pubitemid 28307655)
10. Deng, J.W., Shon, J.H., Shin, H.J., Park, S.J., Yeo, C.W., Zhou, H.H., Song, I.S., Shin, J.G., 2008. Effect of silymarin supplement on the pharmacokinetics of rosuvastatin. Pharm. Res. 25, 1807-1814.
11. Dixon, M., 1953. The determination of enzyme inhibitor constants. Biochem. J. 55, 170-171.
12. i. Biochem. J. 129, 197-202.
13. Fuchikami, H., Satoh, H., Tsujimoto, M., Ohdo, S., Ohtani, H., Sawada, Y., 2006. Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab. Dispos. 34, 577-582.
14. Glaeser, H., Bailey, D.G., Dresser, G.K., Gregor, J.C., Schwarz, U.I., McGrath, J.S., Jolicoeur, E., Lee, W., Leake, B.F., Tirona, R.G., Kim, R.B., 2007. Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin. Pharmacol. Ther. 81, 362-370. (Pubitemid 46364477)
15. Glaeser, H., Mandery, K., Sticht, H., Fromm, M.F., König, J., 2010. Relevance of conserved lysine and arginine residues in transmembrane helices for the transport activity of organic anion transporting polypeptide 1B3. Br. J. Pharmacol. 159, 698-708.
16. Graefe, E.U., Wittig, J., Mueller, S., Riethling, A.K., Uehleke, B., Drewelow, B., Pforte, H., Jacobasch, G., Derendorf, H., Veit, M., 2001. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol. 41, 492-499. (Pubitemid 32381866)
17. Hertog, M., Hollman, P., Katan, M., 1992. Content of potentially anticarcinogenic flavonoids of 28 vegetables and nine fruits commonly consumed in the Netherlands. J. Agric. Food Chem. 40, 2379-2383.
18. Hertog, M.G., Feskens, E.J., Hollman, P.C., Katan, M.B., Kromhout, D., 1993. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342, 1007-1011. (Pubitemid 23314801)
19. Hollman, P.C., de Vries, J.H., van Leeuwen, S.D., Mengelers, M.J., Katan, M.B., 1995. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 62, 1276-1282.
20. Ito, K., Iwatsubo, T., Kanamitsu, S., Ueda, K., Suzuki, H., Sugiyama, Y., 1998. Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver. Pharmacol. Rev. 50, 387-412.
21. Jagtap, S., Meganathan, K., Wagh, V., Winkler, J., Hescheler, J., Sachinidis, A., 2009. Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr. Med. Chem. 16, 1451-1462.
22. Kanaze, F.I., Bounartzi, M.I., Georgarakis, M., Niopas, I., 2007. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur. J. Clin. Nutr. 61, 472-477. (Pubitemid 46605217)
23. König, J., 2011. Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms. Handb. Exp. Pharmacol., 1-28.
24. König, J., Cui, Y., Nies, A.T., Keppler, D., 2000a. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J. Biol. Chem. 275, 23161-23168. (Pubitemid 30646210)
25. König, J., Cui, Y., Nies, A.T., Keppler, D., 2000b. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am. J. Physiol. Gastrointest. Liver Physiol. 278, G156-164. (Pubitemid 30108080)
26. Lilja, J.J., Kivistö, K.T., Neuvonen, P.J., 1999. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin. Clin. Pharmacol. Ther. 66, 118-127. (Pubitemid 29398847)
27. Manach, C., Scalbert, A., Morand, C., Rémésy, C., Jiménez, L., 2004. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79, 727-747. (Pubitemid 41103873)
28. Mandery, K., Bujok, K., Schmidt, I., Keiser, M., Siegmund, W., Balk, B., König, J., Fromm, M.F., Glaeser, H., 2010. Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. Biochem. Pharmacol. 80, 1746-1753.
29. Moon, Y.J., Wang, L., DiCenzo, R., Morris, M.E., 2008. Quercetin pharmacokinetics inhumans. Biopharm. Drug Dispos. 29, 205-217.
30. Neuvonen, P.J., Niemi, M., Backman, J.T., 2006. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin. Pharmacol. Ther. 80, 565-581. (Pubitemid 44908269)
31. Nies, A.T., Koepsell, H., Damme, K., Schwab, M., 2011. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. Handb. Exp. Pharmacol., 105-167.
32. Nies, A.T., Koepsell, H., Winter, S., Burk, O., Klein, K., Kerb, R., Zanger, U.M., Keppler, D., Schwab, M., Schaeffeler, E., 2009. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology 50, 1227-1240.
33. Pal, D., Mitra, A.K., 2006. MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci. 78, 2131-2145.
34. Seithel, A., Eberl, S., Singer, K., Auge, D., Heinkele, G., Wolf, N.B., Dörje, F., Fromm, M.F., König, J., 2007. The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3. Drug Metab. Dispos. 35, 779-786. (Pubitemid 46641549)
35. Sergent, T., Dupont, I., Van der Heiden, E., Scippo, M.L., Pussemier, L., Larondelle, Y., Schneider, Y.J., 2009. CYP1A1 and CYP3A4 modulation by dietary flavonoids in human intestinal Caco-2 cells. Toxicol. Lett. 191, 216-222.
36. Vavricka, S.R., Van Montfoort, J., Ha, H.R., Meier, P.J., Fattinger, K., 2002. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Hepatology 36, 164-172. (Pubitemid 34700774)
37. Wang, X., Wolkoff, A.W., Morris, M.E., 2005. Flavonoids as anovel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators. Drug Metab. Dispos. 33, 1666-1672. (Pubitemid 41539965)
38. Wynne, H.A., Cope, L.H., Mutch, E., Rawlins, M.D., Woodhouse, K.W., James, O.F., 1989. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 9, 297-301. (Pubitemid 19063317)